Purchases and Sales Made in Q4 2022 in Kinnate Biopharma Inc. (KNTE)
This table provides information about the institutional ownership of Kinnate Biopharma Inc. (KNTE) during Q4 2022. The information is specifically focused on institutions that hold shares of Kinnate Biopharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2023
Q4 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-5.81K- 2.63% |
$30.6K - $70.8K
|
215K
$0
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-6.24K- 90.07% |
$32.8K - $76K
|
688
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-7.07K- 9.05% |
$37.2K - $86.1K
|
71K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-12.3K- 11.12% |
$64.9K - $151K
|
98.7K
$0
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-14.8K- 33.13% |
$77.8K - $180K
|
29.9K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-20.8K- 48.0% |
$109K - $253K
|
22.5K
$0
|
|
|
Feb 09, 2023
Q4 2022
|
Victory Capital Management Inc
|
SELL
|
- |
-44.5K- 38.54% |
$234K - $543K
|
71K
$0
|
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-128K- 63.94% |
$672K - $1.56M
|
72K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-128K- 63.94% |
$672K - $1.56M
|
72K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-308K- 100.0% |
$1.62M - $3.75M
|
4
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Nextech Invest Ag
|
SELL
|
- |
-332K- 12.49% |
$1.75M - $4.05M
|
2.33M
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-337K- 64.28% |
$1.77M - $4.11M
|
187K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Boxer Capital, LLC
San Diego, CA |
SELL
|
- |
-1.01M- 66.5% |
$5.33M - $12.3M
|
510K
$0
|